Percutaneous tibial nerve stimulation (PTNS) is performed by a range of licensed healthcare professionals, not exclusively surgeons or physicians. Urologists and urogynecologists are the most common providers, but nurse practitioners, trained nurses, and in some cases other qualified clinicians also deliver the treatment. The procedure itself is minimally invasive, involving a thin needle placed near the ankle rather than any surgical incision, which is part of why the circle of eligible providers is broader than many patients expect.
What the Procedure Actually Involves
Understanding who can perform PTNS starts with understanding what the procedure requires technically. A healthcare provider inserts a thin-gauge needle (typically 34-gauge, about the width of an acupuncture needle) near the inner ankle, roughly three finger-widths above the bony bump called the medial malleolus. An electrode pad is placed on the foot, and a handheld stimulator sends a mild electrical current through the needle to the posterior tibial nerve. That nerve shares a pathway with the sacral nerves that control bladder function, so stimulating it indirectly modulates the signals driving an overactive bladder.1MDPI. The Investigation of Percutaneous Tibial Nerve Stimulation (PTNS) as a Minimally Invasive, Non-Surgical, Non-Hormonal Treatment for Overactive Bladder Symptoms The provider confirms correct needle placement by watching for a toe-flex or plantar-flexion response on the same side.
Sessions last about 30 minutes, once a week, for a standard course of 12 weeks. If symptoms improve, patients typically transition to maintenance sessions every few weeks. The technique has its roots in traditional Chinese acupuncture and was first described in the medical literature in the early 1980s.2PubMed Central. Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome Because the procedure does not involve sedation, an operating room, or any tissue cutting, the skills required are closer to those of placing an intravenous line or performing acupuncture than performing surgery.
Physicians and Specialist Providers
Urologists and urogynecologists are the providers most commonly associated with PTNS in the United States. The AUA/SUFU (American Urological Association/Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction) guideline on overactive bladder is written for “clinicians of all specialties” and includes PTNS among the recommended treatment options for patients who have not responded adequately to behavioral therapies or medications.3PubMed Central / The Journal of Urology. The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder That phrasing is intentional: the guideline does not restrict its recommendations to urologists alone. Obstetrician-gynecologists, colorectal surgeons, and other physicians who manage pelvic floor conditions also perform or oversee PTNS in clinical practice.
In settings where PTNS is used for fecal incontinence rather than bladder problems, colorectal and gastroenterology specialists are often the ordering or supervising physicians. Evidence supports PTNS for fecal incontinence as well: across multiple studies, the vast majority showed statistically significant improvement in incontinence episodes and bowel symptom scores after treatment.4Ovid / Obstetrical & Gynecological Survey. Posterior Tibial Nerve Stimulation for the Treatment of Fecal Incontinence: A Systematic Evidence Review The provider performing the procedure in these contexts varies by institution and local regulation, but the physician prescribing and overseeing treatment is typically the specialist managing the underlying condition.
Nurses and Nurse Practitioners
This is where many patients are surprised. PTNS does not require a physician to be in the room for every session in most practice settings. Nurse practitioners and specially trained registered nurses routinely perform the procedure, particularly in community-based and outpatient clinics. One published analysis of an independent, nurse practitioner-led continence practice found that patients receiving PTNS experienced significant decreases in both daytime and nighttime voiding frequency as well as urge incontinence episodes, confirming that the treatment works just as well in a nurse-run community setting as in a physician’s office.5PubMed. Percutaneous tibial nerve stimulation for the treatment of urinary frequency, urinary urgency, and urge incontinence: results from a community-based clinic
The key factor is training, not medical degree. The device used (the Urgent PC system is the most widely known FDA-cleared device in the U.S.) requires proper instruction in anatomical landmarks, needle insertion technique, stimulation parameters, and monitoring for the correct response. Once a nurse or nurse practitioner has received that training, the procedure falls comfortably within the scope of practice for a provider who already has experience with needle-based procedures and patient assessment.
In pediatric settings, the picture is similar. A study of children with lower urinary tract dysfunction found that needle insertion and stimulation were performed by a specialized, trained pediatric nurse, with a topical anesthetic applied beforehand by parents to reduce needle anxiety. A psychological support worker was on hand during sessions for children who needed reassurance.6PubMed Central. Posterior Tibial Nerve Stimulation in Children with Lower Urinary Tract Dysfunction: A Mixed-Methods Analysis of Experiences, Quality of Life and Treatment Effect Children in this study received treatment in a group setting of three to six patients at a time, which further illustrates that the procedure is safe and routine enough to be delivered outside of a one-on-one physician encounter.
Physical Therapists and the Transcutaneous Distinction
The role of pelvic health physical therapists in tibial nerve stimulation is real but comes with an important caveat about terminology. In the United States, pelvic floor physical therapists commonly use transcutaneous tibial nerve stimulation (TTNS), which delivers electrical current through surface electrode pads placed on the skin near the ankle rather than through a needle. A survey of U.S. pelvic health physical therapists found that roughly 30% reported using TTNS as a first-line therapy alongside behavioral and lifestyle modifications for overactive bladder.7Journal of Women’s & Pelvic Health Physical Therapy. Physical Therapist Practice Patterns Utilizing Transcutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder
Percutaneous and transcutaneous tibial nerve stimulation target the same nerve and work by the same principle, but the percutaneous version uses a needle, while the transcutaneous version uses skin electrodes. This matters for scope of practice because needle insertion is considered an invasive procedure in most U.S. states, and many state physical therapy practice acts do not authorize physical therapists to perform needle-based interventions (dry needling is a separate and contentious exception that varies state by state). So when you see a physical therapist offering “tibial nerve stimulation,” it is almost always the transcutaneous form.
How does efficacy compare? Randomized trials have found no significant difference in symptom improvement or quality-of-life scores between percutaneous and transcutaneous delivery.8PubMed Central. Efficacy of Percutaneous vs Transcutaneous Posterior Tibial Nerve Stimulation in Overactive Bladder Syndrome: A Randomized Clinical Trial Another trial found that both methods produced similar clinical gains, though the transcutaneous version scored better on patient comfort and had shorter preparation time.9Annals of Physical and Rehabilitation Medicine. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial For patients who prefer to avoid needles or who receive their care from a physical therapist, the transcutaneous option offers a non-invasive pathway to similar results.
What Insurance Requirements Mean for Who Performs It
Insurance coverage quietly shapes which providers deliver PTNS in practice. Medicare and many private insurers cover PTNS for overactive bladder, but they attach conditions. Noridian, one of the major Medicare administrative contractors, expects the treatment to be delivered in an office setting and stipulates that the patient must have first tried and failed anticholinergic drug therapy, or demonstrated intolerance to those medications. The standard covered course is one 30-minute session per week for 12 weeks, with maintenance sessions available every three weeks for up to two years in patients who respond.10Noridian Healthcare Solutions. Posterior Tibial Nerve Stimulation Coverage
These requirements matter for the “who performs it” question because billing codes for PTNS are typically filed under a physician’s or nurse practitioner’s National Provider Identifier. In many states, a registered nurse can administer the treatment under a physician’s order and supervision, but the supervising physician’s name appears on the claim. The practical effect is that PTNS is most commonly offered in urology or urogynecology offices where the billing infrastructure already exists. Community-based nurse practitioner clinics can also bill for the service independently in states where nurse practitioners have full practice authority.
If a patient is considering PTNS, calling the provider’s office to verify both insurance coverage and whether the treating clinician has received device-specific training is a reasonable step. The credential that matters most is not the provider’s specialty title but whether they have been trained on the specific stimulation device being used and whether the clinic can handle billing and documentation for the 12-session course.
Safety Profile and the Training It Requires
PTNS has an unusually mild side-effect profile for a procedure that involves needle insertion, which is another reason why it does not require a surgeon to perform. A review of adverse effects found that the most common were minor pain at the needle site (about 6% of patients), slight bleeding (about 5%), and occasional hematoma, swelling, or localized muscle cramping, all at roughly 1% each.11Obstetrics & Gynecology International Journal. Percutaneous tibial nerve stimulation associated with occipital headaches: a review of the adverse effects of percutaneous tibial nerve stimulation A systematic review and meta-analysis similarly concluded that pain at the puncture site was the main complication, and the incidence was low.12PubMed. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis
The rare vasovagal response (feeling faint in reaction to the needle) is the same risk seen with blood draws and vaccinations. None of the documented complications require surgical intervention or are unique to PTNS. This safety profile is precisely what allows the procedure to be performed by a trained nurse rather than exclusively by a physician: the risks are manageable with basic clinical monitoring skills, and there is no realistic scenario in which a surgical intervention would be needed during a session.
That said, the person holding the needle still needs competence in the relevant anatomy, correct identification of the tibial nerve landmark, the ability to interpret the motor response that confirms proper needle placement, and knowledge of contraindications. PTNS should not be performed on patients with pacemakers or implantable defibrillators, those who are pregnant, patients with bleeding disorders, or people with nerve damage in the treatment leg. Training programs offered by device manufacturers and continuing medical education courses cover all of this, and completion of such training is what qualifies a clinician to perform the procedure rather than any specific board certification.
Why the Repeated Office Visits Matter
One underappreciated factor in the “who performs it” question is the sheer number of visits required. Twelve weekly sessions followed by ongoing maintenance is a substantial time commitment, and this shapes both which clinics offer the procedure and which providers end up delivering it. In a long-term study of over 400 patients, more than 40% of those on maintenance therapy eventually stopped PTNS because of logistic reasons and physical strain rather than because the treatment stopped working.13PubMed Central. Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients
Compliance rates also vary by setting. A study comparing a tertiary academic center with a county hospital found compliance rates of 55% and 70% respectively, with patients at the county hospital having more than five times the odds of completing their treatment course in a multivariable analysis.14PubMed. Compliance with Percutaneous Tibial Nerve Stimulation at a Tertiary Academic Center versus a County Hospital The reasons for dropout are telling: in another evaluation, the primary reason was perceived lack of improvement, followed by time commitment, loss of insurance, and medical comorbidities.15Urology. Evaluation of Percutaneous Tibial Nerve Stimulation Maintenance Therapy Dropout Rates and Compliance Factors Maintenance continuation fell from about 78% at three months to under 40% at one year.
This dropout pattern helps explain why community-based and nurse-led clinics play an important role. A clinic closer to the patient’s home, with flexible scheduling and lower overhead, can reduce the logistic barriers that cause people to abandon a treatment that is otherwise working. When a nurse practitioner or trained nurse can deliver the sessions independently, the procedure does not need to compete for time on a specialist physician’s schedule. The result is better access and, potentially, better adherence.
Emerging Implantable Devices and How They Change the Provider Picture
Newer technologies are beginning to shift the conversation away from repeated office visits entirely. Implantable tibial nerve stimulators, such as the BlueWind RENOVA system and the eCoin device, are small devices placed surgically near the tibial nerve that can deliver stimulation continuously or on a programmable schedule without weekly needle sessions.16PubMed Central. Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines These represent a fundamentally different category: implantation is a minor surgical procedure that requires a physician, typically a urologist or urogynecologist, and an appropriate procedural setting.
Once implanted, however, the ongoing management shifts away from in-office needle sessions entirely. The patient controls stimulation via an external device, and follow-up visits become infrequent check-ins rather than weekly treatment appointments. These implants are not yet as widely available or as thoroughly studied as traditional percutaneous PTNS, but they highlight how the “who performs it” question is not static. The initial implantation requires a surgeon; the ongoing care does not.
Choosing a Provider in Practice
If you are exploring PTNS for overactive bladder or fecal incontinence, the practical advice is straightforward. Start with the specialist managing your condition, whether that is a urologist, urogynecologist, or colorectal surgeon. Ask whether their office performs PTNS in-house and who specifically does the needle insertion. In many practices, the physician will prescribe and oversee the treatment plan while a trained nurse or nurse practitioner performs the weekly sessions.
If your specialist does not offer PTNS, ask about referral to a community-based continence clinic. These nurse practitioner-led practices exist in many areas and can deliver the full 12-week course and maintenance. If needle-based treatment feels daunting or logistically difficult, ask your pelvic floor physical therapist about transcutaneous tibial nerve stimulation. The evidence suggests comparable outcomes with better comfort, and no needle is involved. Your physical therapist can administer the surface-electrode version without any scope-of-practice concerns in most states.
Across all these providers and settings, the common thread is training on the specific device and technique, not a particular medical degree. PTNS sits in a relatively unusual clinical space: effective enough to be recommended in major urology guidelines, simple enough to be safely performed by a trained nurse, and burdensome enough in its visit schedule that making it accessible across multiple provider types genuinely matters for patients who need it.